Skip to main content
SpringerLink
Log in

Management of Hypertensive Emergencies

  • Chapter
  • First Online:
Pediatric Hypertension

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

Abstract

Severe, symptomatic hypertension occurs infrequently in childhood but when present often signifies a life-threatening emergency. The clinician needs to approach this situation with a sense of urgency to reduce blood pressure (BP) and limit end-organ damage while avoiding overly aggressive therapy, which may also lead to ischemia and further injury. This chapter discusses the causes, pathophysiology, evaluation, and treatment of severe hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

BBB:

Blood-brain barrier

BP:

Blood pressure

ECG:

Electrocardiogram

ICD:

International classification of diseases

IV:

Intravenous

JNC:

Joint National Committee

PKC:

Protein kinase C

PRES:

Posterior reversible leukoencephalopathy syndrome

References

  1. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, editor. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents, NIH publication, vol. 05-5267. Bethesda: National Heart Lung Blood Institute/National Institute of Health; 2005.

    Google Scholar 

  2. Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens. 2009;27(9):1719–42.

    Article  CAS  PubMed  Google Scholar 

  3. McNiece KL, Poffenbarger TS, Turner JL, Franco KD, Sorof JM, Portman RJ. Prevalence of hypertension and pre-hypertension among adolescents. J Pediatr. 2007;150(6):640–4.

    Article  PubMed  Google Scholar 

  4. Croix B, Feig DI. Childhood hypertension is not a silent disease. Pediatr Nephrol. 2006;21(4):527–32.

    Article  PubMed  Google Scholar 

  5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–52.

    Article  CAS  PubMed  Google Scholar 

  6. Varon J. Treatment of acute severe hypertension: current and newer agents. Drugs. 2008;68(3):283–97.

    Article  CAS  PubMed  Google Scholar 

  7. Marik PE, Varon J. Hypertensive crises: challenges and management. Chest. 2007;131(6):1949–62.

    Article  CAS  PubMed  Google Scholar 

  8. ICD-9-CM guidelines, conversions & tabular, sixth edition. Available from http://www.cdc.gov/nchs/icd/icd9cm.htm. Accessed 5 Sept 2012.

  9. Adelman R, Coppo R, Dillon M. The emergency management of severe hypertension. Pediatr Nephrol. 2000;14(5):422–7.

    Article  CAS  PubMed  Google Scholar 

  10. Flynn J, Tullus K. Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol. 2009;24:1101–12.

    Article  PubMed  Google Scholar 

  11. Still JL, Cottom D. Severe hypertension in childhood. Arch Dis Child. 1967;42:34–9.

    Article  CAS  PubMed  Google Scholar 

  12. Deal JE, Barratt TM, Dillon MJ. Management of hypertensive emergencies. Arch Dis Child. 1992;67(9):1089–92.

    Article  CAS  PubMed  Google Scholar 

  13. Daniels SR, Loggie JM, McEnery PT, Towbin RB. Clinical spectrum of intrinsic renovascular hypertension in children. Pediatrics. 1987;80(5):698–704.

    CAS  PubMed  Google Scholar 

  14. Wu H-P, Yang W-C, Wu Y-K, Zhao L-L, Chen C-Y, Fu Y-C. Clinical significance of blood pressure ratios in hypertensive crisis in children. Arch Dis Child. 2012;97(3):200–5.

    Article  PubMed  Google Scholar 

  15. Strandgaard S, Olesen J, Skinhøj E, Lassen NA. Autoregulation of brain circulation in severe arterial hypertension. BMJ. 1973;1:507–10.

    Article  CAS  PubMed  Google Scholar 

  16. Strandgaard S, Paulson OB. Cerebral autoregulation. Stroke. 2009;15(3):413–6.

    Article  Google Scholar 

  17. Vavilala MS, Lee LA, Lam AM. Cerebral blood flow and vascular physiology. Anesthesiol Clin North America. 2002;20(2):247–64.

    Article  PubMed  Google Scholar 

  18. Paulson OB, Waldemar G, Schmidt JF, Strandgaard S. Cerebral circulation under normal and pathologic conditions. Am J Cardiol. 1989;63(6):2C–5.

    Article  CAS  PubMed  Google Scholar 

  19. Volpe JJ. Hypoxic-ischemic encephalopathy: biochemical and physiological aspects. In: Neurology of the newborn. 5th ed. Philadelphia: Saunders Elsevier; 2008. p. 291–324.

    Google Scholar 

  20. Pryds O, Edwards AD. Cerebral blood flow in the newborn infant. Arch Dis Child Fetal Neonatal Ed. 1996;74(1):F63–9.

    Article  CAS  PubMed  Google Scholar 

  21. Vavilala MS, Newell DW, Junger E, Douville CM, Aaslid R, Rivara FP, et al. Dynamic cerebral autoregulation in healthy adolescents. Acta Anaesthesiol Scand. 2002;46(4):393–7.

    Article  CAS  PubMed  Google Scholar 

  22. Vavilala MS, Kincaid MS, Muangman SL, Suz P, Rozet I, Lam AM. Gender differences in cerebral blood flow velocity and autoregulation between the anterior and posterior circulations in healthy children. Pediatr Res. 2005;58(3):574–8.

    Article  PubMed  Google Scholar 

  23. Tontisirin N, Muangman SL, Suz P, Pihoker C, Fisk D, Moore A, et al. Early childhood gender differences in anterior and posterior cerebral blood flow velocity and autoregulation. Pediatrics. 2007;119(3):e610–5.

    Article  PubMed  Google Scholar 

  24. Sharma M, Kupferman JC, Brosgol Y, Paterno K, Goodman S, Prohovnik I, et al. The effects of hypertension on the paediatric brain: a justifiable concern. Lancet Neurol. 2010;9(9):933–40.

    Article  PubMed  Google Scholar 

  25. Wong LJ, Kupferman JC, Prohovnik I, Kirkham FJ, Goodman S, Paterno K, et al. Hypertension impairs vascular reactivity in the pediatric brain. Stroke. 2011;42(7):1834–8.

    Article  PubMed  Google Scholar 

  26. Gardner CJ, Lee K. Hyperperfusion syndromes: insight into the pathophysiology and treatment of hypertensive encephalopathy. CNS Spectr. 2007;12(1):35–42.

    PubMed  Google Scholar 

  27. Immink RV, van den Born B-JH, van Montfrans GA, Koopmans RP, Karemaker JM, van Lieshout JJ. Impaired cerebral autoregulation in patients with malignant hypertension. Circulation. 2004;110(15):2241–5.

    Article  PubMed  Google Scholar 

  28. Immink RV, van den Born B-JH, van Montfrans GA, Kim Y-S, Hollmann MW, van Lieshout JJ. Cerebral hemodynamics during treatment with sodium nitroprusside versus labetalol in malignant hypertension. Hypertension. 2008;52(2):236–40.

    Article  CAS  PubMed  Google Scholar 

  29. Qi X, Inagaki K, Sobel RA, Mochly-Rosen D. Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood–brain barrier breakdown in rats. J Clin Invest. 2008;118(1):173–82.

    CAS  PubMed  Google Scholar 

  30. Chou W-H, Messing RO. Hypertensive encephalopathy and the blood–brain barrier: is deltaPKC a gatekeeper? J Clin Invest. 2008;118(1):17–20.

    Article  CAS  PubMed  Google Scholar 

  31. Flynn J.: Management of hypertensive emergencies and urgencies in children. Up to date. Available from http://www.utdol.com. Accessed 1 Sept 2012.

  32. Patel HP, Mitsnefes M. Advances in the pathogenesis and management of hypertensive crisis. Curr Opin Pediatr. 2005;17(2):210–4.

    Article  PubMed  Google Scholar 

  33. Blumenfeld JD, Laragh JH. Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens. 2001;14(11 Pt 1):1154–67.

    Article  CAS  PubMed  Google Scholar 

  34. Flynn JT, Woroniecki RP. Pathophysiology of hypertension. In: Pediatric nephrology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 1153–77.

    Google Scholar 

  35. Grossman E, Messerli FH. Secondary hypertension: interfering substances. J Clin Hypertens (Greenwich). 2008;10(7):556–66.

    Article  CAS  Google Scholar 

  36. Groshong T. Hypertensive crisis in children. Pediatr Ann. 1996;25(7):368–71. 375–6.

    CAS  PubMed  Google Scholar 

  37. Fivush B, Neu A, Furth S. Acute hypertensive crises in children: emergencies and urgencies. Curr Opin Pediatr. 1997;9(3):233–6.

    Article  CAS  PubMed  Google Scholar 

  38. Chandar J, Zilleruelo G. Hypertensive crisis in children. Pediatr Nephrol. 2012;27:741–51.

    Article  PubMed  Google Scholar 

  39. Horn DG, Trame MN, Hempel G. The management of hypertensive emergencies in children after stem cell transplantation. Int J Clin Pharm. 2011;33(2):165–76.

    Article  CAS  PubMed  Google Scholar 

  40. Hari P, Sinha A. Hypertensive emergencies in children. Indian J Pediatr. 2011;78(5):569–75.

    Article  PubMed  Google Scholar 

  41. Flynn JT, Mottes TA, Brophy PD, Kershaw DB, Smoyer WE, Bunchman TE. Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr. 2001;139(1):38–43.

    Article  CAS  PubMed  Google Scholar 

  42. Constantine E, Linakis J. The assessment and management of hypertensive emergencies and urgencies in children. Pediatr Emerg Care. 2005;21(6):391–6. quiz 397.

    Article  PubMed  Google Scholar 

  43. Bender SR, Fong MW, Heitz S, Bisognano JD. Characteristics and management of patients presenting to the emergency department with hypertensive urgency. J Clin Hypertens (Greenwich). 2006;8(1):12–8.

    Article  Google Scholar 

  44. Sorof JM, Brewer ED, Portman RJ. Ambulatory blood pressure monitoring and interdialytic weight gain in children receiving chronic hemodialysis. Am J Kidney Dis. 1999;33(4):667–74.

    Article  CAS  PubMed  Google Scholar 

  45. Mitsnefes M, Stablein D. Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis. 2005;45(2):309–15.

    Article  PubMed  Google Scholar 

  46. Geyskes GG, Boer P, Dorhout Mees EJ. Clonidine withdrawal. Mechanism and frequency of rebound hypertension. Br J Clin Pharmacol. 1979;7(1):55–62.

    Article  CAS  PubMed  Google Scholar 

  47. Farine M, Arbus GS. Management of hypertensive emergencies in children. Pediatr Emerg Care. 1989;5(1):51–5.

    Article  CAS  PubMed  Google Scholar 

  48. Suresh S, Mahajan P, Kamat D. Emergency management of pediatric hypertension. Clin Pediatr (Phila). 2005;44(9):739–45.

    Article  Google Scholar 

  49. Wright RR, Mathews KD. Hypertensive encephalopathy in childhood. J Child Neurol. 1996;11(3):193–6.

    Article  CAS  PubMed  Google Scholar 

  50. Hu M-H, Wang H-S, Lin K-L, Huang J-L, Hsia S-H, Chou M-L, et al. Clinical experience of childhood hypertensive encephalopathy over an eight year period. Chang Gung Med J. 2008;31(2):153–8.

    PubMed  Google Scholar 

  51. Trompeter RS, Smith RL, Hoare RD, Neville BG, Chantler C. Neurological complications of arterial hypertension. Arch Dis Child. 1982;57(12):913–7.

    Article  CAS  PubMed  Google Scholar 

  52. Harms MM, Rotteveel JJ, Kar NC, Gabreëls FJ. Recurrent alternating facial paralysis and malignant hypertension. Neuropediatrics. 2000;31(6):318–20.

    Article  CAS  PubMed  Google Scholar 

  53. Lewis VE, Peat DS, Tizard EJ. Hypertension and facial palsy in middle aortic syndrome. Arch Dis Child. 2001;85(3):240–1.

    Article  CAS  PubMed  Google Scholar 

  54. Tirodker UH, Dabbagh S. Facial paralysis in childhood hypertension. J Paediatr Child Health. 2001;37(2):193–4.

    Article  CAS  PubMed  Google Scholar 

  55. Skalina ME, Annable WL, Kliegman RM, Fanaroff AA. Hypertensive retinopathy in the newborn infant. J Pediatr. 1983;103(5):781–6.

    Article  CAS  PubMed  Google Scholar 

  56. Browning A, Mengher L, Gregson R, Amoaku WM. Visual outcome of malignant hypertension in young people. Arch Dis Child. 2001;85(5):401–3.

    Article  CAS  PubMed  Google Scholar 

  57. Shroff R, Roebuck DJ, Gordon I, Davies R, Stephens S, Marks S, et al. Angioplasty for renovascular hypertension in children: 20-year experience. Pediatrics. 2006;118(1):268–75.

    Article  PubMed  Google Scholar 

  58. Madre C, Orbach D, Baudouin V, Brisse H, Bessa F, Schleiermacher G, et al. Hypertension in childhood cancer: a frequent complication of certain tumor sites. J Pediatr Hematol Oncol. 2006;28(10):659–64.

    Article  PubMed  Google Scholar 

  59. Grinsell M, Norwood V. At the bottom of the differential diagnosis list: unusual causes of pediatric hypertension. Pediatr Nephrol. 2008;24(1):2137–46.

    PubMed  Google Scholar 

  60. Fossali E, Signorini E, Intermite RC, Casalini E, Lovaria A, Maninetti MM, et al. Renovascular disease and hypertension in children with neurofibromatosis. Pediatr Nephrol. 2000;14(8–9):806–10.

    Article  CAS  PubMed  Google Scholar 

  61. Pitfield AF, Carroll AB, Kissoon N. Emergency management of increased intracranial pressure. Pediatr Emerg Care. 2012;28(2):200–4. quiz 205–7.

    PubMed  Google Scholar 

  62. Belsha CW. Pediatric hypertension in the emergency department. Ann Emerg Med. 2008;51(3 Suppl):S21–3.

    Article  PubMed  Google Scholar 

  63. Barton JR. Hypertension in pregnancy. Ann Emerg Med. 2008;51(3 Suppl):S16–7.

    Article  PubMed  Google Scholar 

  64. Roth CG, Spottswood SE, Chan JCM, Roth KS. Evaluation of the hypertensive infant: a rational approach to diagnosis. Radiol Clin North Am. 2003;41(5):931–44.

    Article  PubMed  Google Scholar 

  65. Tullus K, Brennan E, Hamilton G, Lord R, McLaren CA, Marks SD, et al. Renovascular hypertension in children. Lancet. 2008;371:1453–63.

    Article  CAS  PubMed  Google Scholar 

  66. Pavlakis SG, Frank Y, Chusid R. Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. J Child Neurol. 1999;14(5):277–81.

    Article  CAS  PubMed  Google Scholar 

  67. Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol. 2001;24(5):361–4.

    Article  CAS  PubMed  Google Scholar 

  68. Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Shishido S, Asanuma H, et al. Posterior reversible encephalopathy syndrome in children: its high prevalence and more extensive imaging findings. Am J Kidney Dis. 2006;48(2):231–8.

    Article  PubMed  Google Scholar 

  69. Prasad N, Gulati S, Gupta RK, Sharma K, Gulati K, Sharma RK, et al. Spectrum of radiological changes in hypertensive children with reversible posterior leukoencephalopathy. Br J Radiol. 2007;80:422–9.

    Article  CAS  PubMed  Google Scholar 

  70. Onder AM, Lopez R, Teomete U, Francoeur D, Bhatia R, Knowbi O, et al. Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol. 2007;22(11):1921–9.

    Article  PubMed  Google Scholar 

  71. Sanjay KM, Partha PC. The posterior reversible encephalopathy syndrome. Indian J Pediatr. 2008;75(9):953–5.

    Article  PubMed  Google Scholar 

  72. Gümüş H, Per H, Kumandaş S, Yikilmaz A. Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature. Neurol Sci. 2010;31(2):125–31.

    Article  PubMed  Google Scholar 

  73. Shahdadpuri J, Frank R, Gauthier BG, Siegel DN, Trachtman H. Yield of renal arteriography in the evaluation of pediatric hypertension. Pediatr Nephrol. 2000;14(8–9):816–9.

    Article  CAS  PubMed  Google Scholar 

  74. Vade A, Agrawal R, Lim-Dunham J, Hartoin D. Utility of computed tomographic renal angiogram in the management of childhood hypertension. Pediatr Nephrol. 2002;17(9):741–7.

    Article  PubMed  Google Scholar 

  75. Cherney D, Straus S. Management of patients with hypertensive urgencies and emergencies: a systematic review of the literature. J Gen Intern Med. 2002;17(12):937–45.

    Article  PubMed  Google Scholar 

  76. Holt TR, Withington DE, Mitchell E. Which pressure to believe? A comparison of direct arterial with indirect blood pressure measurement techniques in the pediatric intensive care unit. Pediatr Crit Care Med. 2011;13(6):1–4.

    Google Scholar 

  77. Rhoney D, Peacock WF. Intravenous therapy for hypertensive emergencies, part 1. Am J Health Syst Pharm. 2009;66(15):1343–52.

    Article  CAS  PubMed  Google Scholar 

  78. Rhoney D, Peacock WF. Intravenous therapy for hypertensive emergencies, part 2. Am J Health Syst Pharm. 2009;66(16):1448–57.

    Article  CAS  PubMed  Google Scholar 

  79. Messerli FH, Eslava DJ. Treatment of hypertensive emergencies: blood pressure cosmetics or outcome evidence? J Hum Hypertens. 2008;22(9):585–6.

    Article  CAS  PubMed  Google Scholar 

  80. Peacock WF, Hilleman DE, Levy PD, Rhoney DH, Varon J. A systematic review of nicardipine vs labetalol for the management of hypertensive crises. Am J Emerg Med. 2012;30(6):981–93.

    Article  PubMed  Google Scholar 

  81. Kohaut EC, Wilson CJ, Hill LL. Intravenous diazoxide in acute poststreptococcal glomerulonephritis. J Pediatr. 1975;87(5):795–8.

    Article  CAS  PubMed  Google Scholar 

  82. McLaine PN, Drummond KN. Intravenous diazoxide for severe hypertension in childhood. J Pediatr. 1971;79(5):829–32.

    Article  CAS  PubMed  Google Scholar 

  83. McCrory WW, Kohaut EC, Lewy JE, Lieberman E, Travis LB. Safety of intravenous diazoxide in children with severe hypertension. Clin Pediatr (Phila). 1979;18(11):661–3. 666–7, 671.

    Article  CAS  Google Scholar 

  84. Flynn JT. Safety of short-acting nifedipine in children with severe hypertension. Expert Opin Drug Saf. 2003;2(2):133–9.

    Article  CAS  PubMed  Google Scholar 

  85. Porto I. Hypertensive emergencies in children. J Pediatr Health Care. 2000;14(6):312–7. quiz 318–9.

    CAS  PubMed  Google Scholar 

  86. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA. 1996;276(16):1328–31.

    Article  CAS  PubMed  Google Scholar 

  87. Blaszak RT, Savage JA, Ellis EN. The use of short-acting nifedipine in pediatric patients with hypertension. J Pediatr. 2001;139(1):34–7.

    Article  CAS  PubMed  Google Scholar 

  88. Egger DW, Deming DD, Hamada N, Perkin RM, Sahney S. Evaluation of the safety of short-acting nifedipine in children with hypertension. Pediatr Nephrol. 2002;17(1):35–40.

    Article  PubMed  Google Scholar 

  89. Yiu V, Orrbine E, Rosychuk RJ, MacLaine P, Goodyer P, Girardin C, et al. The safety and use of short-acting nifedipine in hospitalized hypertensive children. Pediatr Nephrol. 2004;9(6):644–50.

    Article  Google Scholar 

  90. Calvetta A, Martino S, von Vigier RO, Schmidtko J, Fossali E, Bianchetti MG. “What goes up must immediately come down!” Which indication for short-acting nifedipine in children with arterial hypertension? Pediatr Nephrol. 2003;18(1):1–2.

    Article  CAS  PubMed  Google Scholar 

  91. Leonard MB, Kasner SE, Feldman HI, Schulman SL. Adverse neurologic events associated with rebound hypertension after using short-acting nifedipine in childhood hypertension. Pediatr Emerg Care. 2001;17(6):435–7.

    Article  CAS  PubMed  Google Scholar 

  92. Castaneda MP, Walsh CA, Woroniecki RP, Del Rio M, Flynn JT. Ventricular arrhythmia following short-acting nifedipine administration. Pediatr Nephrol. 2005;20(7):1000–2.

    Article  PubMed  Google Scholar 

  93. Truttmann AC, Zehnder-Schlapbach S, Bianchetti MG. A moratorium should be placed on the use of short-acting nifedipine for hypertensive crises. Pediatr Nephrol. 1998;12(3):259.

    CAS  PubMed  Google Scholar 

  94. Sasaki R, Hirota K, Masuda A. Nifedipine-induced transient cerebral ischemia in a child with Cockayne syndrome. Anaesthesia. 1997;52(12):1236.

    CAS  PubMed  Google Scholar 

  95. Gordillo-Paniagua G, Velásquez-Jones L, Martini R, Valdez-Bolaños E. Sodium nitroprusside treatment of severe arterial hypertension in children. J Pediatr. 1975;87(5):799–802.

    Article  CAS  PubMed  Google Scholar 

  96. Luderer JR, Hayes AH, Dubnsky O, Berlin CM. Long-term administration of sodium nitroprusside in childhood. J Pediatr. 1977;91(3):490–1.

    Article  CAS  PubMed  Google Scholar 

  97. Hoffman B. Therapy of hypertension. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gillman’s the pharmacological basis of therapeutics. 11th ed., New York: McGraw Hill; 2006. p. 845–68.

    Google Scholar 

  98. Thomas C, Svehla L, Moffett BS. Sodium-nitroprusside-induced cyanide toxicity in pediatric patients. Expert Opin Drug Saf. 2009;8(5):599–602.

    Article  CAS  PubMed  Google Scholar 

  99. Goa KL, Benfield P, Sorkin EM. Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease. Drugs. 1989;37(5):583–627.

    Article  CAS  PubMed  Google Scholar 

  100. Rose JC, Mayer SA. Optimizing blood pressure in neurological emergencies. Neurocrit Care. 2004;1(3):287–99.

    Article  PubMed  Google Scholar 

  101. Pancioli AM. Hypertension management in neurological emergencies. Ann Emerg Med. 2008;51 Suppl 3:S24–7.

    Article  PubMed  Google Scholar 

  102. Bunchman TE, Lynch RE, Wood EG. Intravenously administered labetalol for treatment of hypertension in children. J Pediatr. 1992;120(1):140–4.

    Article  CAS  PubMed  Google Scholar 

  103. Thomas CA, Moffett BS, Wagner JL, Mott AR, Feig DI. Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children. Pediatr Crit Care Med. 2011;12(1):28–32.

    Article  PubMed  Google Scholar 

  104. Adams HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Circulation. 2007;115(20):e478–534.

    Article  PubMed  Google Scholar 

  105. Curran MP, Robinson DM, Keating GM. Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications. Drugs. 2006;66(13):1755–82.

    Article  CAS  PubMed  Google Scholar 

  106. Treluyer JM, Hubert P, Jouvet P, Couderc S, Cloup M. Intravenous nicardipine in hypertensive children. Eur J Pediatr. 1993;152(9):712–4.

    Article  CAS  PubMed  Google Scholar 

  107. Gouyon JB, Geneste B, Semama DS, Françoise M, Germain JF. Intravenous nicardipine in hypertensive preterm infants. Arch Dis Child Fetal Neonatal Ed. 1997;76(2):F126–7.

    Article  CAS  PubMed  Google Scholar 

  108. Michael J, Groshong T, Tobias JD. Nicardipine for hypertensive emergencies in children with renal disease. Pediatr Nephrol. 1998;12(1):40–2.

    Article  CAS  PubMed  Google Scholar 

  109. Tenney F, Sakarcan A. Nicardipine is a safe and effective agent in pediatric hypertensive emergencies. Am J Kidney Dis. 2000;35(5):E20.

    Article  CAS  PubMed  Google Scholar 

  110. Milou C, Debuche-Benouachkou V, Semama DS, Germain JF, Gouyon JB. Intravenous nicardipine as a first-line antihypertensive drug in neonates. Intensive Care Med. 2000;26(7):956–8.

    Article  CAS  PubMed  Google Scholar 

  111. McBride BF, White CM, Campbell M, Frey BM. Nicardipine to control neonatal hypertension during extracorporeal membrane oxygen support. Ann Pharmacother. 2003;37(5):667–70.

    Article  PubMed  Google Scholar 

  112. Nakagawa TA, Sartori SC, Morris A, Schneider DS. Intravenous nicardipine for treatment of postcoarctectomy hypertension in children. Pediatr Cardiol. 2004;25(1):26–30.

    Article  CAS  PubMed  Google Scholar 

  113. Baaske DM, DeMay JF, Latona CA, Mirmira S, Sigvardson KW. Stability of nicardipine hydrochloride in intravenous solutions. Am J Health Syst Pharm. 1996;53(14):1701–5.

    CAS  PubMed  Google Scholar 

  114. Hooper DK, Carle AC, Schuchter J, Goebel J. Interaction between tacrolimus and intravenous nicardipine in the treatment of post-kidney transplant hypertension at pediatric hospitals. Pediatr Transplant. 2011;15(1):88–95.

    Article  PubMed  Google Scholar 

  115. Tabbutt S, Nicolson SC, Adamson PC, Zhang X, Hoffman ML, Wells W, et al. The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial. J Thorac Cardiovasc Surg. 2008;136(2):321–8.

    Article  CAS  PubMed  Google Scholar 

  116. Adamson PC, Rhodes LA, Saul JP, Dick M, Epstein MR, Moate P, et al. The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias. Pediatr Cardiol. 2006;27(4):420–7.

    Article  PubMed  Google Scholar 

  117. Murphy MB, Murray C, Shorten GD. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med. 2001;345(21):1548–57.

    Article  CAS  PubMed  Google Scholar 

  118. Moffett BS, Mott AR, Nelson DP, Goldstein SL, Jefferies JL. Renal effects of fenoldopam in critically ill pediatric patients: a retrospective review. Pediatr Crit Care Med. 2008;9(4):403–6.

    Article  PubMed  Google Scholar 

  119. Hammer GB, Verghese ST, Drover DR, Yaster M, Tobin JR. Pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients. BMC Anesthesiol. 2008;8:6.

    Article  PubMed  CAS  Google Scholar 

  120. Lechner BL, Pascual JF, Roscelli JD. Failure of fenoldopam to control severe hypertension secondary to renal graft rejection in a pediatric patient. Mil Med. 2005;170(2):130–2.

    PubMed  Google Scholar 

  121. Wells TG, Bunchman TE, Kearns GL. Treatment of neonatal hypertension with enalaprilat. J Pediatr. 1990;117(4):664–7.

    Article  CAS  PubMed  Google Scholar 

  122. Deeks ED, Keating GM, Keam SJ. Clevidipine: a review of its use in the management of acute hypertension. Am J Cardiovasc Drugs. 2009;9(2):117–34.

    Article  CAS  PubMed  Google Scholar 

  123. Pollack CV, Varon J, Garrison NA, Ebrahimi R, Dunbar L, Peacock WF. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. Ann Emerg Med. 2009;53(3):329–38.

    Article  PubMed  Google Scholar 

  124. Towe E, Tobias JD. Preliminary experience with clevidipine in the pediatric population. J Intensive Care Med. 2010;25(6):349–52.

    Article  PubMed  Google Scholar 

  125. Tobias JD, Schechter WS, Phillips A, Weinstein S, Michler R, Berkenbosch JW, et al. Clevidipine for perioperative blood pressure control in infants and children undergoing cardiac surgery for congenital heart disease. J Pediatr Pharmacol Ther. 2011;16(1):55–60.

    PubMed  Google Scholar 

  126. Tobias JD, Hoernschemeyer DG. Clevidipine for controlled hypotension during spinal surgery in adolescents. J Neurosurg Anesthesiol. 2011;23:347–51.

    Article  PubMed  Google Scholar 

  127. Houston MC. Treatment of hypertensive emergencies and urgencies with oral clonidine loading and titration. Arch Intern Med. 1986;146(3):586–9.

    Article  CAS  PubMed  Google Scholar 

  128. Falkner B, Onesti G, Lowenthal DT, Affrime MB. The use of clonidine monotherapy in adolescent hypertension. Chest. 1983;83(2 Suppl):425–7.

    CAS  PubMed  Google Scholar 

  129. Falkner B, Thanki B, Lowenthal DT. Transdermal clonidine in the treatment of adolescent hypertension. J Hypertens Suppl. 1985;3(4):S61–3.

    CAS  PubMed  Google Scholar 

  130. Sahney S. A review of calcium channel antagonists in the treatment of pediatric hypertension. Paediatr Drugs. 2006;8(6):357–73.

    Article  PubMed  Google Scholar 

  131. Flynn JT, Pasko DA. Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension. Pediatr Nephrol. 2000;15(3–4):302–16.

    Article  CAS  PubMed  Google Scholar 

  132. MacDonald JL, Johnson CE, Jacobson P. Stability of isradipine in an extemporaneously compounded oral liquid. Am J Hosp Pharm. 1994;51(19):2409–11.

    CAS  PubMed  Google Scholar 

  133. Johnson CE, Jacobson PA, Song MH. Isradipine therapy in hypertensive pediatric patients. Ann Pharmacother. 1997;31(6):704–7.

    CAS  PubMed  Google Scholar 

  134. Strauser LM, Groshong T, Tobias JD. Initial experience with isradipine for the treatment of hypertension in children. South Med J. 2000;93(3):287–93.

    CAS  PubMed  Google Scholar 

  135. Flynn JT, Warnick SJ. Isradipine treatment of hypertension in children: a single-center experience. Pediatr Nephrol. 2002;17(9):748–53.

    Article  PubMed  Google Scholar 

  136. Miyashita Y, Peterson D, Rees JM, Flynn JT. Isradipine for treatment of acute hypertension in hospitalized children and adolescents. J Clin Hypertens (Greenwich). 2010;12(11):850–5.

    Article  CAS  Google Scholar 

  137. Saragoça MA, Portela JE, Plavnik F, Ventura RP, Lotaif L, Ramos OL. Isradipine in the treatment of hypertensive crisis in ambulatory patients. J Cardiovasc Pharmacol. 1992;19 Suppl 3:S76–8.

    PubMed  Google Scholar 

  138. Pennisi AJ, Takahashi M, Bernstein BH, Singsen BH, Uittenbogaart C, Ettenger RB, et al. Minoxidil therapy in children with severe hypertension. J Pediatr. 1977;90(5):813–9.

    Article  CAS  PubMed  Google Scholar 

  139. Strife CF, Quinlan M, Waldo FB, Fryer CJ, Jackson EC, Welch TR, et al. Minoxidil for control of acute blood pressure elevation in chronically hypertensive children. Pediatrics. 1986;78(5):861–5.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Saint Louis University, SSM Cardinal Glennon Children’s Medical Center, 1465 S. Grand Blvd., St. Louis Missouri, 63104, USA

    Craig W. Belsha M.D.

Authors
  1. Craig W. Belsha M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Craig W. Belsha M.D. .

Editor information

Editors and Affiliations

  1. University of Washington, Division of Pediatrics, Seattle Children's Hospital, Sand Point Way NE. 4800, Seattle, 98105, Washington, USA

    Joseph T. Flynn

  2. Harvard Medical School, Pediatric Nephrology Unit, MassGeneral Hospital for Children at MGH, Fruit St. 55, Boston, 02114, Massachusetts, USA

    Julie R. Ingelfinger

  3. Global Clinical Research, Bristol-Myers Squibb, Route 206 & Provinceline Road, Princeton, 08543, New Jersey, USA

    Ronald J. Portman

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Belsha, C.W. (2013). Management of Hypertensive Emergencies. In: Flynn, J., Ingelfinger, J., Portman, R. (eds) Pediatric Hypertension. Clinical Hypertension and Vascular Diseases. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-490-6_37

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-490-6_37

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-489-0

  • Online ISBN: 978-1-62703-490-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation